Auricular acupuncture for chemically dependent pregnant women: a randomized controlled trial of the NADA protocol

Substance Abuse Treatment, Prevention, and Policy

Ron Abrahams²  Paul Thiessen¹  Anne Kelly³  Louise C Demorest⁴  Patricia A Janssen⁴ 

[1] Dept. of Pediatrics, University of British Columbia, British Columbia, Canada;Dept of Medicine, University of British Columbia, British Columbia, Canada;Toronto Central Local Health Integration Network, Toronto, ON, Canada;School of Population and Public Health, Child and Family Research Institute, University of British Columbia, 2206 East Mall, Vancouver, BC, Canada V6T-1Z3

关键词: Neonatal abstinence syndrome;    Substance abuse;    Pregnancy;    Addiction;    Acupuncture;   

Others  :  834450
DOI  :  10.1186/1747-597X-7-48

 received in 2012-05-01, accepted in 2012-12-10,  发布年份 2012

【 摘 要 】

Background

The prevalence of maternal drug use during pregnancy in North America has been estimated to be as high as 6-10%. The consequences for the newborn include increased risk for perinatal mortality and ongoing physical, neurobehavioral, and psychosocial problems. Methadone is frequently used to wean women off street drugs but is implicated as a cause of adverse fetal/neonatal outcomes itself. The purpose of our study was to test the ability of maternal acupuncture treatment among mothers who use illicit drugs to reduce the frequency and severity of withdrawal symptoms among their newborns.

Methods

We randomly assigned chemically dependent pregnant women at BC Women’s Hospital in Vancouver, British Columbia to daily acupuncture treatments versus usual care. By necessity, neither our participants nor acupuncturists were blinded as to treatment allocation. Our primary outcome was days of neonatal morphine treatment for symptoms of neonatal withdrawal. Secondary neonatal outcomes included admission to a neonatal ICU and transfer to foster care.

Results

We randomized 50 women to acupuncture and 39 to standard care. When analyzed by randomized groups, we did not find benefit of acupuncture; the average length of treatment with morphine for newborns in the acupuncture group was 2.7 (6.3) compared to 2.8 (7.0) in the control group. Among newborns of women who were compliant with the acupuncture regime, we observed a reduction of 2.1 and 1.5 days in length of treatment for neonatal abstinence syndrome compared to the non-compliant and control groups, respectively. These differences were not statistically significant.

Conclusions

Acupuncture may be a safe and feasible treatment to assist mothers to reduce their dosage of methadone. Our results should encourage ongoing studies to test the ability of acupuncture to mitigate the severity of neonatal abstinence syndrome among their newborns.

Clinical Trial Registration

http://www.clinicaltrials.gov webcite registry: W05-0041

【 授权许可】

   
2012 Janssen et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Albersheime S: Infants of drug-dependent mothers. Can J Pediatr 1992, 4:70-72.
• [2]Arria A, Derauf C, Lagasse L, Grant P, Shad E, Smith L, et al.: Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment and Lifestyle (IDEAL) study. Matern Child Health J 2006, 10(3):293-302.
• [3]Finnegan L (Ed): Neonatal Abstinence. Hamilton (Ont): Decker; 1990.
• [4]Finnegan L, Kandall S (Eds): Maternal and neonatal effects of alcohol and drugs. Baltimore: Williams & Wilkins; 1993.
• [5]Alkalay A, Pomerance J, Hamlett H: Substance abuse and the newborn. Review, management and practice guidelines: part II. Neonatal Intensive Care 1997, 10(7):44-46.
• [6]Dattell B: Substance abuse in pregnancy. Semin Perinatol 1990, 14(2):179-187.
• [7]D’Apolito K: Symptoms of withdrawal in drug-exposed infants. Mother Baby J 1996, 1(2):7-14.
• [8]Chasnoff I: Newborn infants with drug withdrawal symptoms. Pediatr Rev 1988, 9:273-277.
• [9]Fergusson D, Horwood L, Sjannon F, Lawton J: The Christchurch child development study: a review of epidemiological findings. Paediatr Perinat Epidemiol 1989, 3:278-301.
• [10]Madden J, Chapel J, Zuspan F, Gumpel J, Mefia A, Davis R: Observation and treatment of neonatal narcotic withdrawal. Am J Obstet Gynecol 1977, 127(2):199-201.
• [11]Wong S, Ordean A, Kahan M: SOGC clinical practice guidelines: substance use in pregnancy, No. 156. Int J Obstet Gynecol 2011, 114:190-202.
• [12]Brown H, Britton K, Mahaffay D, Brizendine E, Hiett A, Turnquest M: Methadone maintenance in pregnancy; a reappraisal. Am J Obstet Gynecol 1998, 179(2):459-463.
• [13]Jones H, Martin P, Heil S, Kaltenbach K, Selby P, Coyle M, et al.: Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat 2008, 35:245-259.
• [14]Jones H, O’Grady K, Malfi D, Tuten M: Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict 2008, 17:372-386.
• [15]Hagopian G, Wolfe H, Sokol R, Ager J, Wardell J, Cepeda E: Neonatal outcome following methadone exposure in utero. J Matern Fetal Med 1996, 1996(5):348-354.
• [16]Hulse G, Milne E, English D, Holman C: The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 1997, 92:1571-1579.
• [17]Hunt R, Tzioumi D, Collins E, Jeffery H: Adverse neurodevelopmental outcome of infants exposed to opiate in-utero. Early Hum Dev 2008, 84:29-35.
• [18]Hulse G, O’Neill G: Methadone and the pregnant user: a matter for careful clinical consideration. Aust N Z J Obstet Gynaecol 2001, 41(3):329-332.
• [19]Hunt R, Tzioumi D, Collins E, Jeffrey H: Adverse neurodevelopmental outcome of infants exposed to opiate in utero. Early Hum Dev 2008, 84(1):29-35.
• [20]McGlone L, Mactier H, Hamilton R, Bradnam M, Boulton R, Borland W: Visual evoked potentials in infants exposed to methadone in utero. Arch Dis Child 2008, 93(3):784-786.
• [21]Lejeune C, Aubisson S, Simmat-Durand L, Cneude F, Piquet M, Gourarier L, Le Group d’Etudes Grossesse et Addictions: Withdrawal syndromes of newborns of pregnant drug abusers maintained under methadone or high-dose buprenorphine: 246 cases. [French]. Ann Med Intern (Paris) 2001, 152(Suppl.(7)):21-27.
• [22]Dashe J, Sheffield J, Olscher D, Todd S, Jackson G, Wendel G: Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecol 2002, 100:1244-1249.
• [23]Cleary B, Donnelly J, Strawbridge D, Gallagher P, Fahey T, Clarke T, et al.: Methadone dose and neonatal abstinence syndrome -systematic review and meta-analysis. Addiction 2010, 104:2071-2084.
• [24]Cleary B, Donnelly J, Strawbridge D, Gallagher P, Fahey T, White M, et al.: Methadone and perinatal outcmes: a retrospective cohort study. Am J Obstet Gynecol 2011, 204(139):e1-e9.
• [25]Thajam D, Atkinson D, Sibley C, Lavender T: Is neonatal abstinence syndrome related to the amount of opiate used? JOGNN 2010, 39:503-509.
• [26]Cleary B, Eogan M, O’Connell M, Fahey T, Gallagher P, Clarke G, et al.: Methadone and perinatal outcomes: a prospective cohort study. Addiction 2012, 107(8):1482-1492.
• [27]Malpas T, Darlow B, Lennox R, Horwood L: Maternal methadone dosage and neonatal withdrawal. Austr NZ J Obstetr Gynaecol 1995, 35:175-177.
• [28]Jones H, Kaltenbach K, Heil S, Stine S, Coyle M, Arria A, et al.: Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010, 363:2320-2331.
• [29]Ahn A, Martinsen O: Electrical characterization of acupuncture points: technical issues and challenges. J Altern Complement Med 2007, 13:817-824.
• [30]Colbert A, Spaulding K, Ahn A, Cutro J: Clinical untility of electrodermal activity at acupuncture points: a narrative review. Acupunct Med 2011, 29:270-275.
• [31]Hsiu H, Hsu W, Hsu C, Huang S: Assessing the effects of acupuncture by comparing needling the hegu acupoint and needling nearby nonacupoints by spectral analysis of microcirculatory laser doppler signals. Evid Based Complement Alternat Med 2011.
• [32]Avants S, Margolin A, Holgord T, Kosten T: A randomized controlled trial of auricular acupuncture for cocaine dependence. Arch Intern Med 2000, 160(15):2305-2313.
• [33]Gurevich M, Duckworth D, Imhof J, Katz J: Is auricular acupuncture beneficial in the inpatient treatment of substance-abusing patients? a pilot study. J Subst Abuse Treat 1996, 13:165-171.
• [34]Janssen P, Demorest L, Whynot E: Acupuncture for substance abuse treatment in the Downtown Eastside of Vancouver. J Urban Health 2005, 12(2):285-295.
• [35]Lipton D, Brewington V, Smith M: Acupuncture for crack-cocaine detoxification: experimental evaluation of efficiacy. J Subst Abuse Treat 1994, 11(3):205-215.
• [36]Smith F: Neurophysiologic basis of acupuncture. Probl Vet Med 1992, 4(1):34-52.
• [37]Levine D: Acupuncture in review: a mechanistic perspective. Am J Acupunct 1980, 8(1):5-17.
• [38]Wang Y, Wang S: Effects of phentolamine and propanolol on the changes of pain threshold and contents of MEK and LEK in rat brain after EA. J Tradit Chin Med 1988, 9(3):210-214.
• [39]Pan X, Zhang B, Wang D: Electro-acupuncture analgesia and analgesic action of NAGA. J Tradit Chin Med 1984, 4(4):273-278.
• [40]Culliton P, Kiresuk T: Overview of substance abuse acupuncture treatment research. J Altern Complement Med 1996, 2(1):149-159.
• [41]Barrios De Tomasi E, Juárez-González J: Opioid antagonists and alcohol consumption. Rev Neurol 2007, 3:155-162.
• [42]Wen H: Role of acupuncture in narcotic withdrawal. Med Pr 1975, 2:15-16.
• [43]Smith M: Acupuncture and natural healing in drug detoxification. Am J Acupunct 1979, 7(2):97-107.
• [44]British Columbia Reproductive Care Program: Perinatal opioid exposure, care of the newborn, substance Use guideline 4B. Vancouver: British Columbia Reproductive Care Program; 1999.
• [45]Weinberger S, Kandal S, Doberczak T, Thornton J, Bernstein J: Early weight-change patterns in neonatal abstinence. Am J Dis Child 1986, 140(8):829-832.
• [46]Finnegan L, Connaughton J, Kron R, Emich J: Neonatal abstinence syndrome: assessment and management. Addict Disord 1975, 2(1–2):141-158.
• [47]Elliott M, Cunliffe P, Demianczuk N, Robertson C: Frequency of newborn behaviours associated with neonatal abstinence syndrome. J Obstet Gynecol Can 2004, 26(1):25-34.
• [48]Kandall S: Treatment strategies for drug-exposed neonates. Clin Perinatology 1999, 26(2):231-243.
• [49]Coghlan D, Milner M, Clarke T: Neonatal abstinence syndrome. Ir Med J 1999, 92:232-236.
• [50]Richardson R, Bolisetty S, Ingall C: The profile of substance-abusing pregnant mothers and their newborns at a regional rural hospital in New South Wales. Austr NZ J Obstet Gynaecol 2001, 41(4):415-419.
• [51]Avants S, Margolin A, Chang P, Kosten T, Birch S: Acupuncture for the treatment of cocaine addiction - investigation of needle puncture control. J Subst Abuse Treat 1995, 12:195-205.
• [52]He L: Review article: involvement of endogenous opioid peptides in acupuncture analgesia. Pain 1987, 31:99-121.
• [53]Margolin A, Chang P, Avants S, Dosten T: Effects of sham and acupuncture needling: implications for trials of acupuncture for cocaine addiction. Am J Chin Med 1993, 21:102-111.
• [54]Abrahams R, Kelly A, Payne S, Thiessen P, Mackintosh J, Janssen P: Outcomes of a rooming-in program for women maintained on methadone. Can Fam Physician 2007, 53(10):1722-1730.
• [55]Jansson L, Velez M, Harrow C: The opioid exposed newborn: assessment and pharmacologic management. J Opioid Man 2009, 5:47-55.